Neuroscience awards named for Barres
The five-year awards from the Chan Zuckerberg Initiative will help fuel research into the biology of neurodegenerative diseases. The awards honor a Stanford neuroscientist who died in December.
Iron triggers lung transplant infection
Iron enables a common mold to take root in lung transplant recipients, according to Stanford researchers who led a study that offers a new perspective for understanding and treating these pulmonary infections.
Schneider on disease and data sculptures
Many infectious diseases, including malaria, are marked by cyclical ups and downs. David Schneider takes a creative approach to making sense of those ups and downs.
Drug Discovery Conference set for April 23-24
The two-day conference at Stanford will bring together experts from academia, industry and government to discuss drug policy, research and business opportunities.
Gerald Reaven, who coined ‘Syndrome X,’ dies
Gerald Reaven’s decades of research at Stanford helped show that insulin resistance could lead to Type 2 diabetes and multiple other diseases.
A detailed look at school revenue, expenses
Among other things, the School of Medicine meeting focused on the costs of facilities maintenance and the formula for funding departments, programs and support for faculty.
Low-fat or low-carb? It’s a draw
Stanford researchers have found that, contrary to previous studies, insulin levels and a specific genotype pattern don’t predict weight-loss success.
Scope blog debuts new look
Stanford Medicine’s award-winning blog, Scope, has a refreshed, mobile-friendly design.
Seizure-regulating nerve cells identified
Stanford researchers have found that a small set of nerve cells in the brain regulates the debilitating seizures and cognitive deficits characteristic of the most common form of epilepsy in adults. This discovery could lead to new and better treatments.
Patients, caregivers tell their stories
The Stanford Storybank features conversations between two people about learning, connecting and healing.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.